Literature DB >> 26919137

Properties and antimicrobial susceptibility of Trueperella pyogenes isolated from bovine mastitis in China.

Rashad Alkasir1, Jianfang Wang2, Jian Gao1, Tariq Ali1, Limei Zhang1, Ottó Szenci3,4, Árpád Csaba Bajcsy3,4, Bo Han1.   

Abstract

Trueperella (T.) pyogenes is an opportunistic pathogen that causes suppurative diseases in domestic animals. In this work, the properties, pathogenesis and phenotypic diversity of T. pyogenes isolates from bovine mastitis were studied. Both pyolysin (plo) and collagen-binding protein (cbp) virulence factor genes were detected by PCR in all T. pyogenes isolates (n = 50). Using the tissue culture plate method, 90% of T. pyogenes isolates were able to form biofilms. The minimum inhibitory concentrations (MICs) of 13 antimicrobials against T. pyogenes isolates were determined. High susceptibility was observed to rifampin (96%), ampicillin (94%), ciprofloxacin (94%), and penicillin (92%), while low susceptibility was found to trimethoprim-sulphamethoxazole (10%) and bacitracin (2%). The intracellular assay revealed that T. pyogenes isolates had different cytopathogenic effects on cells. The high percentage (28.6%) of T. pyogenes isolates suggests that this bacterium is an important contributor to mastitis. Moreover, the high occurrence of multidrug resistance, biofilm production, intracellular survival, and the temporal dynamics of T. pyogenes interactions are key factors for a better understanding of how immunity acts on infections with these bacteria and how they evade immune surveillance, thus highlighting the need for the prudent use of antimicrobial agents in veterinary medicine.

Entities:  

Keywords:  Trueperella pyogenes; antimicrobial susceptibility; biofilm; bovine mastitis; virulence factor

Mesh:

Substances:

Year:  2016        PMID: 26919137     DOI: 10.1556/004.2016.001

Source DB:  PubMed          Journal:  Acta Vet Hung        ISSN: 0236-6290            Impact factor:   0.955


  7 in total

1.  Association of toll-like receptors 2 and 6 polymorphism with clinical mastitis and production traits in Holstein cattle.

Authors:  M M Elmaghraby; A F El-Nahas; M M Fathala; F M Sahwan; M A Tag El-Dien
Journal:  Iran J Vet Res       Date:  2018       Impact factor: 1.376

Review 2.  Antimicrobial usage and resistance in beef production.

Authors:  Andrew Cameron; Tim A McAllister
Journal:  J Anim Sci Biotechnol       Date:  2016-12-12

3.  Molecular Basis for Luteolin as a Natural TatD DNase Inhibitor in Trueperella pyogenes.

Authors:  Zehui Zhang; Yuru Guo; Yueting Guo; Luyao Zhang; Shengli Niu; Chunlian Tian; Limei Han; Dexian Zhang; Mingchun Liu
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

4.  Differences in phenotypic and genetic characteristics of Trueperella pyogenes detected in slaughtered cattle and pigs with septicemia.

Authors:  Hideki Fujimoto; Natsuki Shimoji; Tatsumi Sunagawa; Kaoru Kubozono; Chikage Nakajima; Takehisa Chuma
Journal:  J Vet Med Sci       Date:  2020-03-24       Impact factor: 1.267

5.  Phenotypic and molecular characterization of antimicrobial resistance in Trueperella pyogenes strains isolated from bovine mastitis and metritis.

Authors:  Mobin Rezanejad; Sepideh Karimi; Hassan Momtaz
Journal:  BMC Microbiol       Date:  2019-12-27       Impact factor: 3.605

6.  Effect of intramolecular disulfide bond of bovine lactoferricin on its molecular structure and antibacterial activity against Trueperella pyogenes separated from cow milk with mastitis.

Authors:  Jie Pei; Lin Xiong; Min Chu; Xian Guo; Ping Yan
Journal:  BMC Vet Res       Date:  2020-10-23       Impact factor: 2.741

7.  Antimicrobial Susceptibility Profile of Several Bacteria Species Identified in the Peritoneal Exudate of Cows Affected by Parietal Fibrinous Peritonitis after Caesarean Section.

Authors:  Salem Djebala; Julien Evrard; Fabien Gregoire; Calixte Bayrou; Linde Gille; Justine Eppe; Hélène Casalta; Vincent Frisée; Nassim Moula; Arnaud Sartelet; Damien Thiry; Philippe Bossaert
Journal:  Vet Sci       Date:  2021-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.